Presentation TCT 2021 SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure Presenter: Roberto Galea November 06, 2021
News Conference News TCT 2021 Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter? Todd Neale November 06, 2021
News Conference News TCT 2021 PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021
News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Daily News FDA Investigating Possible Sex Differences in LAAO Outcomes Todd Neale September 27, 2021
News Daily News Delayed Peridevice Leak Not Uncommon After Watchman Implant Todd Neale September 03, 2021
News Conference News ESC 2021 Amulet IDE: LAA Occluder Performs Well Against Watchman Todd Neale August 30, 2021
News Conference News HRS 2021 RF-Based Energy Closes Residual Leaks After Watchman Implantation Michael O'Riordan August 09, 2021
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
Presentation TVT 2021 How Has the Watchman FLX Improved Outcomes vs Watchman 2.5? Presenter: Brijeshwar Maini July 22, 2021
News Daily News Predictors of Device-Related Thrombus Following LAA Occlusion Shelley Wood July 19, 2021
Video » Interview SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure November 5, 2021